Cargando…

Duration of antibiotic treatment for Gram-negative bacteremia – Systematic review and individual participant data (IPD) meta-analysis

BACKGROUND: We aim to compare the effect of short versus long treatment duration in Gram-negative bacteremia on all-cause mortality in pre-specified sub-groups. METHODS: Individual participant data meta-analysis of randomized controlled trials (RCTs) comparing short (≤7) versus longer (>7 days) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turjeman, Adi, von Dach, Elodie, Molina, José, Franceschini, Erica, Koppel, Fidi, Yelin, Dana, Dishon-Benattar, Yael, Mussini, Cristina, Rodríguez-Baño, Jesús, Cisneros, José Miguel, Huttner, Angela, Paul, Mical, Leibovici, Leonard, Yahav, Dafna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722443/ https://www.ncbi.nlm.nih.gov/pubmed/36483269 http://dx.doi.org/10.1016/j.eclinm.2022.101750

Ejemplares similares

Optimizing patient recruitment into clinical trials of antimicrobial-resistant pathogens
por: Paul, Mical, et al.
Publicado: (2023)

Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study
por: Turjeman, Adi, et al.
Publicado: (2021)

Piperacillin–tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)
por: Bitterman, Roni, et al.
Publicado: (2021)

Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity
por: Daitch, Vered, et al.
Publicado: (2021)

A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection
por: Howard-Anderson, Jessica, et al.
Publicado: (2022)

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol
por: Dickstein, Yaakov, et al.
Publicado: (2016)

Is shorter always better? The pros and cons of treating Gram-negative bloodstream infections with 7 days of antibiotics
por: Yahav, Dafna, et al.
Publicado: (2022)

Underrepresentation of women in randomized controlled trials: a systematic review and meta-analysis
por: Daitch, Vered, et al.
Publicado: (2022)

A systematic review assessing the under-representation of elderly adults in COVID-19 trials
por: Prendki, Virginie, et al.
Publicado: (2020)

External validity of a randomised controlled trial on the treatment of severe infections caused by MRSA
por: Paul, Mical, et al.
Publicado: (2015)

Risk factors for treatment failure in women with uncomplicated lower urinary tract infection
por: Martischang, Romain, et al.
Publicado: (2021)

The association of vancomycin trough levels with outcomes among patients with methicillin-resistant Staphylococcus aureus (MRSA) infections: Retrospective cohort study
por: Yahav, Dafna, et al.
Publicado: (2019)

Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii
por: Kon, Hadas, et al.
Publicado: (2023)

Predicting In-Hospital Antibiotic Use in the Medical Department: Derivation and Validation Study
por: Poran, Itamar, et al.
Publicado: (2022)

What have we learned from the first to the second wave of COVID-19 pandemic? An international survey from the ESCMID Study Group for Infection in the Elderly (ESGIE) group
por: Tiseo, Giusy, et al.
Publicado: (2021)

Predictors of Readmission Following Discharge of Patients With Gram-Negative Bacteremia: A Retrospective Cohort Study
por: Porat, Yanay, et al.
Publicado: (2021)

Predictors of survival in elderly patients with coronavirus disease 2019 admitted to the hospital: derivation and validation of the FLAMINCOV score()
por: Tiseo, Giusy, et al.
Publicado: (2023)

Oral iron supplements for children in malaria‐endemic areas
por: Neuberger, Ami, et al.
Publicado: (2016)

Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial
por: Paul, Mical, et al.
Publicado: (2015)

Assessing the impact of coronavirus disease 2019 on mortality: a population-based, matched case-control study
por: Turjeman, Adi, et al.
Publicado: (2023)

IPD3 and IPD3L Function Redundantly in Rhizobial and Mycorrhizal Symbioses
por: Jin, Yue, et al.
Publicado: (2018)

PRIME-IPD SERIES Part 1. The PRIME-IPD tool promoted verification and standardization of study datasets retrieved for IPD meta-analysis
por: Dewidar, Omar, et al.
Publicado: (2021)

Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia
por: Abe, Ryuzo, et al.
Publicado: (2010)

Long COVID-19—it's not over until?
por: Yelin, Dana, et al.
Publicado: (2021)

Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study
por: Babich, Tanya, et al.
Publicado: (2022)

IPD—the Immuno Polymorphism Database
por: Robinson, James, et al.
Publicado: (2005)

IPD—the Immuno Polymorphism Database
por: Robinson, James, et al.
Publicado: (2010)

IPD—the Immuno Polymorphism Database
por: Robinson, James, et al.
Publicado: (2013)

IPD-IMGT/HLA Database
por: Robinson, James, et al.
Publicado: (2020)

The IPD-IMGT/HLA Database
por: Barker, Dominic J, et al.
Publicado: (2022)

Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis
por: Avni, Tomer, et al.
Publicado: (2015)

Neural Alterations in Interpersonal Distance (IPD) Cognition and Its Correlation with IPD Behavior: A Systematic Review
por: Huang, Xinxin, et al.
Publicado: (2021)

Gram-negative versus Gram-positive bacteremia: what is more alarmin(g)?
por: Alexandraki, Irene, et al.
Publicado: (2010)

Comment on Huang et al. Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis. J. Clin. Med. 2022, 11, 3239
por: Daitch, Vered, et al.
Publicado: (2022)

Long-term consequences of COVID-19: research needs
por: Yelin, Dana, et al.
Publicado: (2020)

PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia
por: Huttner, Angela, et al.
Publicado: (2017)

Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity
por: Yahav, Dafna, et al.
Publicado: (2021)

Immunogenicity and Safety of Modified Vaccinia Ankara (MVA) Vaccine—A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Nave, Lior, et al.
Publicado: (2023)

Strongyloidiasis complicated by gram-negative bacteremia and liver abscesses
por: Ordaya, Eloy E., et al.
Publicado: (2022)

Risk for primary cephalosporin resistance in Gram-negative bacteremia
por: John, Princy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b88r5995759g3nsooeoh4riqvt